MAPPING BRANDS OF NINTEDANIB
Posted in News
Nintedanib is approved by NICE for two separate indications. There are two brand names – one for each indication – but identical products (100mg and 150mg capsules) are used for each indication.
Vargatef® 100mg and 150mg soft capsules are indicated for use in adult patients with locally advanced, metastatic or locally recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first-line chemotherapy (NICE TA347). Ofev® 100mg and 150mg soft capsules are indicated for use in adults for the treatment of Idiopathic Pulmonary Fibrosis (IPF) (NICE TA379).
Though there is no requirement for these to be prescribed by brand, where brand names are included in Trust data, mapping will be at this level to facilitate reporting for the different indications.